A limited number of evolutionarily conserved signal transduction pathways are repeatedly reused during development to regulate a wide range of processes. Here we describe a new negative regulator of JAK/ STAT signaling and identify a potential mechanism by which the pleiotropy of responses resulting from pathway activation is generated in vivo. As part of a genetic interaction screen, we have identified Ken & Barbie (Ken) [1] , which is an ortholog of the mammalian proto-oncogene BCL6 [2], as a negative regulator of the JAK/STAT pathway. Ken genetically interacts with the pathway in vivo and recognizes a DNA consensus sequence overlapping that of STAT92E in vitro. Tissue culture-based assays demonstrate the existence of Ken-sensitive and Ken-insensitive STAT92E binding sites, while ectopically expressed Ken is sufficient to downregulate a subset of JAK/STAT pathway target genes in vivo. Finally, we show that endogenous Ken specifically represses JAK/STAT-dependent expression of ventral veins lacking (vvl) in the posterior spiracles. Ken therefore represents a novel regulator of JAK/STAT signaling whose dynamic spatial and temporal expression is capable of selectively modulating the transcriptional repertoire elicited by activated STAT92E in vivo.
Results and Discussion
Ken Genetically Interacts with JAK/STAT Signaling Analysis of phenotypes associated with mutations in Drosophila JAK/STAT pathway components have identified a wide variety of requirements for the pathway during embryonic development and in adults (reviewed in [3, 4] ). What is less clear is how the repeated stimulation of a single pathway is able to generate this pleiotropy of developmental functions. In order to identify modulators of JAK/STAT signaling that may be involved in this process, we undertook a genetic screen for modifiers of the dominant phenotype caused by the ectopic expression of the pathway ligand Unpaired (Upd) in the developing eye imaginal disc. Such misexpression by GMR-updD3 0 results in overgrowth of the adult eye, a phenotype sensitive to the strength of pathway signaling activity [5] . With this assay, one genomic region, defined by Df(2R)Chi g320 , was found to enhance the GMR-updD3 0 -induced eye overgrowth phenotype. Of the genes deleted by Df(2R)Chi g320 , only mutations in ken showed consistent and reproducible enhancement of the phenotype ( Figures 1A and 1B and not shown). In addition, other dominant phenotypes induced by transgene expression from the GMR promoter are not modulated by ken mutations, indicating that Ken is unlikely to interact with the misexpression construct used (not shown).
The enhancement of the GMR-updD3 0 phenotype after removal of one copy of ken implies that Ken normally functions antagonistically to JAK/STAT signaling. We therefore tested phenotypes associated with mutations in other pathway components to establish the reliability of this initial observation. Consistent with this, genetic interaction assays between ken mutations and the hypomorphic loss-of-function allele stat92E
HJ [6] show a reduction in the frequency of wing vein defects normally associated with this stat92E allele (Figures S1A and S1B in the Supplemental Data available with this article online). Moreover, the degree of suppression is consistent with the strength of ken alleles tested (Supplemental Data and Table S1 ). Similarly, the frequency of ''strong'' posterior spiracle phenotypes caused by the dome 367 allele of the pathway receptor is also reduced when crossed to ken alleles or the Df(2R)Chi g320 deficiency, with a concomitant increase in ''weak'' phenotypes (Table S2 and Figures S1C-S1E).
Thus, multiple independent ken alleles all modify diverse phenotypes caused by both gain-and loss-offunction mutations in multiple JAK/STAT pathway components. Each of these components acts at different levels of the signaling cascade and show interactions indicating that Ken consistently acts as an antagonist of the pathway.
The Ken Locus
The ken locus contains three exons encoding a 601 aa protein ( Figure 1C ) [1, 7, 8] . Ken possesses an N-terminal BTB/POZ domain between aa 17 and 131 and three C-terminal C2H2 zinc finger motifs from aa 502 to 590 ( Figure 1D ). Strikingly, a number of Zn finger-containing proteins that also contain BTB/POZ domains have also been shown to function as transcriptional repressorsoften via the recruitment of corepressors such as SMRT, mSIN3A, N-CoR, and HDAC-1 [9, 10] .
Searches for proteins similar to Ken identified homologs in Drosophila pseudoobscura and the mosquito Anopheles gambiae. In vertebrates, human B-Cell Lymphoma 6 (BCL6) [11] was the closest full-length homolog. Drosophila Ken and human BCL6 share the same *Correspondence: mzeidle@gwdg.dedomain structure and show 20.3% overall identity (Figure 1D ) [12] . Proteins listed as potential vertebrate homologs of Ken in Flybase (http://flybase.bio.indiana. edu) are more distantly related ( Figure 1E ).
Expression of ken was also examined during development, where it is detected in a dynamic pattern from newly laid eggs, throughout embryogenesis ( Figures  2A-2E) , and in imaginal discs (Figures 2H-2J ). As such, endogenous Ken is present in all tissues and stages in which genetic interactions were observed.
Ken Binds to a DNA Sequence that Overlaps that of STAT92E Given the presence of potentially DNA binding Zn finger domains and the nuclear localization of GFPKen (Figures 2K-2N ), we set out to determine the DNA binding properties of Ken by using an in vitro selection technique termed SELEX (systematic evolution of ligands by exponential enrichment) [13] . With a GST-tagged Ken Zn finger domain and a randomized oligonucleotide library, ten successive rounds of selection were undertaken. Sequencing of the resulting oligonucleotide pool and alignment of 43 independent clones showed that all recovered plasmids were unique and each contained one, or occasionally two, copies of the motif GNGAAAK (K = G/T; Table S3 ).
To confirm the SELEX results, we expressed GFPKen in tissue culture cells and used these for electromobility shift assays (EMSA). A radioactively labeled probe containing the wild-type (wt) consensus binding site GAG AAAG gave a specific band, which can be supershifted by an anti-GFP antibody ( Figure 3A ) and therefore represents a GFPKen/DNA complex. In order to identify positions essential for binding, we used a competition assay in which unlabeled oligonucleotides containing single substitutions in each position from 1 to 7 (Table S3) were added to binding reactions. 10-fold excess of unlabeled wild-type consensus oligonucleotide greatly diminished the intensity of the GFPKen band, while 50-and 100-fold excess totally blocked the original signal ( Figure 3B ). By contrast, competition with unlabeled m3 oligonucleotides containing a G to A substitution at position 3 failed to significantly reduce the intensity of the band even at 100-fold excess ( Figure 3B ). With this approach, the positions 1 and 7 are found dispensable for DNA binding, whereas the central GAAA core is absolutely required ( Figure 3B ). Similar results were obtained with the converse experiment with labeled mutant probes, although in this case the wt probe produces a stronger signal than the m1 and m7 mutant oligonucleotides (not shown). Taken together, these experiments not only define the core sequence for Ken binding, but also demonstrate the specificity of Ken as a site-specific DNA binding molecule.
Interestingly, the core consensus bound by Ken is very similar to that identified for human BCL6, with the Zn fingers of the latter binding to a DNA sequence containing a core GAAAG motif [12, 14] .
Ken Selectively Regulates JAK/STAT Reporters in Cell Culture
One initial observation made is that the core GAAA essential for Ken binding overlaps the sequence recognized by STAT92E ( Figure 3C ) [15] . Consistent with this overlap, a 100-fold excess of unlabeled oligonucleotide containing the STAT92E consensus is sufficient to fully compete for Ken in EMSA assays ( Figure 3B ). Given this finding, we hypothesize that the negative regulation of JAK/STAT signaling by Ken observed in genetic interaction assays may occur via a mechanism of competitive DNA binding site occupation. Due to the incomplete overlap between the STAT92E and Ken core sequences ( Figure 3C ), this hypothesis also implies the existence To test this hypothesis, we set up a cell culture-based assay by using a luciferase-expressing reporter containing four STAT92E binding sites ( Figure 3D ) originally identified in the promoter of the Draf locus [16] . In addition to this STAT + /Ken + wild-type reporter, we also generated STAT + /Ken 2 and STAT 2 /Ken 2 variants identical but for the binding sequences shown in Figure 3D . When transfected into the hemocyte-like Kc 167 Drosophila cell line, both STAT + /Ken + and STAT + /Ken 2 reporters showed strong stimulation upon coexpression with the pathway ligand Upd ( Figure 3E ), an assay previously shown to require an intact JAK/STAT cascade [17] . When cotransfected with KenGFP, the activity of the STAT + /Ken + reporter was reduced ( Figure 3E ), an effect reproduced in three independent experiments with both KenGFP and Ken (not shown). While the reduction in reporter activity for the STAT + /Ken + assay shown is statistically significant (p = 0.007), the STAT + /Ken 2 reporter was unaffected by the coexpression of Ken ( Figure 3E ). Reporters containing binding sites mutated to prevent binding of both STAT92E and Ken (STAT 2 / Ken 2 ) showed no activation after pathway stimulation and did not respond to Ken ( Figure 3E ).
These results indicate that Ken functions as a transcriptional repressor in this cell-culture system and shows that this effect is specific to the DNA sequence determined by SELEX and EMSA. This result is also consistent with a recent whole-genome RNAi-based screen, which used a reporter containing STAT + /Ken + binding sites and includes Ken among the list of JAK/STAT regulators identified [18] . In addition, recent reports have also demonstrated BCL6 binding to STAT6 sites in vitro and have shown that BCL6 can act as a repressor of STAT6-dependent target gene expression in cell culture [19, 20] . Although this repression is mediated by the binding to corepressors to the BTB/POZ domain of BCL6 [9] , no link between BCL6 and STAT activity has been demonstrated in vivo.
Finally, it should also be noted that both the STAT + / Ken + and STAT + /Ken 2 reporters contain additional GAAA sequences that are not part of the characterized STAT92E binding sequences. However, despite the presence of these potential Ken binding sites within 15 bp of the STAT92E site, Ken expression did not affect the STAT + /Ken 2 reporter ( Figure 3E ), suggesting that Ken may require STAT92E to influence gene expression. Although we have not been able to demonstrate a direct association between Ken and STAT92E (not shown), we cannot exclude this possibility, and further analysis remains to be undertaken. Ken Is Sufficient to Downregulate a Subset of JAK/STAT Pathway Target Genes In Vivo Having established that Ken functions at the level of DNA binding in cell culture, we asked whether Ken also acts as a transcriptional repressor of JAK/STAT pathway target genes in vivo. For this, we examined the effect of ectopically expressed Ken on the expression of putative JAK/STAT pathway target genes and, given the high levels of maternally loaded STAT92E present at blastoderm stage, we focused on targets expressed later in embryogenesis. These include the hindgut-specific expression of vvl [21] , the expression of trachealess (trh) and knirps (kni) in the tracheal placodes [22] , and the dynamic expression of socs36E throughout the embryo [23] .
First, we addressed the effect of Ken on trh, expression of which precedes the formation of the tracheal pits in the embryonic segments T2 to A8 ( Figures 4A  and 4D ) [22] . Levels of trh are greatly reduced in embryos uniformly misexpressing Ken driven by the daughterless-GAL4 (da-GAL4) line ( Figure 4B ). Many tracheal placodes express little or no trh, and tracheal pits fail to form even in the presence of residual trh ( Figure 4E ). Similar effects are seen in upd OS1A mutant embryos lacking all pathway activity ( Figures 4C and 4F ). Likewise, downregulation of Kni expression is also observed in embryos misexpressing ken ( Figures 4G and 4H ). These results show that both endogenous trh and kni are downregulated by ectopically expressed Ken. We then tested whether Ken can modulate the expression of socs36E, a Drosophila homolog of mouse SOCS-5. socs36E expression closely mirrors that of upd, showing JAK/STAT pathway-dependent upregulation in segmentally repeated stripes, tracheal pits, and the hindgut [23] . By contrast to trh and kni, ectopically expressed Ken does not affect any aspect of socs36E transcription ( Figures 4I and 4J and not shown). However, controls expressing a dominant-negative form of the pathway receptor DomeDCyt [22] , using the same Gal4 driver line, show a strong downregulation of socs36E ( Figure 4K ), an effect reproduced by the complete removal of all JAK/STAT pathway activity by the upd OS1A allele ( Figure 4L ). Taken together, these results illustrate that ectopic expression of Ken during Drosophila development is sufficient to downregulate the expression of only a subset of putative JAK/STAT pathway target genes.
Ken Regulates STAT92E-Induced vvl As part of our analysis, we tested for modulation of vvl by Ken. In wild-type embryos, vvl is expressed in the developing trachea and lateral ectoderm (in a JAK/STATindependent manner) and in the hindgut of stage 12-14 embryos (Figure 5A ), where it requires JAK/STAT signaling [21] . In upd OS1A mutants, no vvl expression in the hindgut can be detected ( [21] and not shown), indicating that this locus is a target of pathway activation. When Ken is uniformly misexpressed throughout the embryo, vvl expression is no longer detectable in the hindgut ( Figure 5C ). Thus vvl, like trh and kni, can be a target of Ken-mediated repression.
Having established that ectopic Ken is sufficient to downregulate vvl in the hindgut, we set out to determine whether endogenous Ken performs a similar role. One overlap between ken expression and regions known to require JAK/STAT signaling are the developing posterior spiracles, structures in which both the pathway ligand upd and ken are simultaneously expressed ( Figures 2F  and 2G ). However, vvl is never detected in the posterior spiracle primordia in wild-type embryos ( Figure 5B), despite JAK/STAT pathway activity induced by upd expression in these tissues [21] . Intriguingly, in a heteroallelic combination of the strongest ken k11035 allele and Df(2R)Chi g320 , vvl transcript was detected not only in its normal expression domain within the hindgut (Figure 5E ) but also in the posterior spiracles ( Figure 5F ). This ectopic expression is initially detected from late stage 13 and rapidly strengthens during stage 14-15. When ken k11035 /Df(2R)Chi g320 embryos simultaneously mutant for the amorphic upd OS1A allele were analyzed, upregulation of vvl in the presumptive posterior spiracles was never observed at the stage by which ectopic vvl expression was first detected in the ken mutant embryos (not shown). At later stages, JAK/STAT pathway activity is required for posterior spiracle morphogenesis [21, 24] , posterior spiracles do not form, and upregulated vvl is not present ( Figure 5H ).
These results demonstrate that Ken is not only sufficient to downregulate the JAK/STAT pathway-dependent expression of vvl in the hindgut, but its endogenous expression is also necessary for vvl repression in the posterior spiracles. In ken mutants, ectopic vvl expression in the posterior spiracles results from a derepression of endogenous STAT92E activity. ; ken k11035 /Df(2R)Chi g230 double mutants, vvl cannot be detected in the hindgut (G). Similarly, no expression is detected in the region normally occupied by the presumptive posterior spiracles that do not form properly in this genotype (H).
Ken as a Selective Transcriptional Regulator
Although studied in some detail, the regulatory domains controlling vvl expression in the developing hindgut have not been identified [26, 27] . Therefore, although our results predict that such a domain would contain STAT + /Ken + binding sequences, further analysis is required to confirm this hypothesis. By contrast, the regulatory domain of socs36E required to drive gene expression in the blastoderm, tracheal pits, and hindgut comprises a 350 bp region containing three STAT + / Ken + and two STAT + /Ken 2 binding sites (M.P.Z., unpublished data). Although not conclusive, the presence of STAT92E-exclusive sites in this region may explain the inability of Ken to downregulate socs36E in vivo ( Figures  4I and 4J) .
Our findings also draw a parallel between Drosophila Ken and BCL6. The data presented demonstrate that both proteins show similar abilities to bind DNA and to mediate transcriptional repression with some evidence also linking BCL6 to JAK/STAT signaling as described here. Taken together, these similarities suggest that Ken and BCL6 represent functional orthologs of one another. Given this evolutionary conservation, it is tempting to speculate that the selective regulation of JAK/ STAT pathway target genes is also conserved and may represent a general mechanism by which the pathway is modulated to elicit diverse developmental roles in vivo. Although many STAT targets undoubtedly remain to be identified, it will be intriguing to see which may also be coregulated by Ken/BCL6-dependent mechanisms.
Experimental Procedures Genetics
Fly stocks used were: Ore R, GMR-updD3 0 [5] , Df(2R)Chi g320 [28] , ken 1 [29] , ken 02970 and ken k11035 [7] , stat92E 06342 [30] , stat92E HJ [6] , sgs3-GAL4 [31] , da-GAL4 [32] , dome 468 and dome 367 [22] , and Df(1)os 1A (referred to as upd OS1A ) [33] . All flies, larvae, and embryos were grown at 25ºC, except for those shown in Figures 1A and 1B , which were grown at 18ºC.
ken alleles were tested for interaction with GMR-Rho1 and GMRyan [34, 35] . For stat92E HJ interactions, both extra and missing wing veins were scored as phenotypic.
DNA Constructs ken cDNA was derived from EST clones GH12495 and LD29702. For misexpression constructs, full-length ken ORF was amplified by PCR and subcloned into pUAST [36] . EGFP-Ken fusions were generated by cloning into pBS-EGFPA or pBS-EGFPB [37] followed by subcloning into pUAST and pAc5.1A (Invitrogen). To tag with GST, Ken DNA binding domain (aa 475 to 601) was amplified and cloned into pGEX-2T (Amersham). All PCR reactions were carried out with PfuTurbo (Stratagene) and confirmed by DNA sequencing.
For luciferase assays, the STAT + /Ken + sites in 2xDrafSTATwt-TATA-luc [16] Histology Salivary glands and embryos were prepared by standard techniques and stained with rabbit anti-Knirps (1:200) [38] , TRITC-phalloidin (Sigma), and DRAQ5 (Biostatus). Whole-mount in situ hybridization was performed as described previously [39] by RNA probes prepared from pCRII-ken, pCRII-vvl, pFLC-1-trh, pOT2-RE54280 (BDGP), and pBS-lacZ. Embryonic cuticles were prepared as described previously [40] . Pictures shown in Figures 2K-2N were captured on a Leica TCS SP2 confocal microscope in sequential scan mode to exclude the possibility of interchannel crosstalk. 2 ) reporters together with 20 ng pActRenilla and 250 ng pAc5.1A empty vector (Invitrogen). For pathway stimulation, cells were cotransfected with 150 ng pAct-updGFP. 10 ng pAct-kenGFP was cotransfected as appropriate with a commensurate decrease in empty vector. After 12 hr, cells were resuspended in fresh medium and 5 3 10 5 cells were seeded into six wells of a 96-well plate. After 72 hr, cells were lysed and measured for Renilla and firefly luciferase activities [17] . Values were normalized based on Renilla luciferase activity and are shown as multiples of the unstimulated level. Error bars represent standard deviation, while p values are derived from a Student's t test.
SELEX

EMSA
To prepare a probe containing STAT92E consensus, the top-strand GGATTTTTCCCGGAAATG and the bottom-strand GACCATTTCCG GGAAAAA oligonucleotides were annealed to give 3 0 overhangs. Similarly, oligonucleotides for Ken binding were designed as a palindromic sequence containing inverted repeats of the consensus obtained by SELEX. All probes were labeled with [ 
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